医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma

广告
第一作者: Pipas,J.M.
作者单位: Department of Medicine, Indiana University School of Medicine, Indianapolis, United States [1] Department of Surgery, Veterans Administration Medical Center, White River Junction, United States [2] Section Surgical Oncology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon [3] Office of Clinical Research, Norris Cotton Cancer Center, Lebanon, United States [4] Section Hematology/Oncology, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon [5] Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, United States [6] Section Radiation Oncology, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon [7] Department of Radiology, Dartmouth-Hitchcock Medical Center, Lebanon, United States [8] Department of Pathology, Brigham and Women's Hospital, Boston, United States [9] Section Gastroenterology, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon [10] Department of Epidemiology and Biostatistics, Dartmouth-Hitchcock Medical Center, Lebanon, United [11]
发布时间 2013-11-20
提交
  • 浏览0
Annals of oncology: official journal of the European Society for Medical Oncology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷